Skip to main content
. Author manuscript; available in PMC: 2015 May 8.
Published in final edited form as: JAMA Neurol. 2015 Apr 1;72(4):432–440. doi: 10.1001/jamaneurol.2014.4380

Table 3.

Characteristics of Included Studies: Outcome Measurements

Source On/Offa Post-rTMS
Evaluation
rTMS Changeb
Active Sham
Siebner et al,42 2000 Off 1 h −7.40 −2.90
Boylan et al,35 2001 Off Immediately NA NA
Shimamoto et al,28 2001 On and off Immediately −8.35 −0.80
Khedr et al,24 2003 Off 1 h and 1 mo −14.3 −0.62
Lefaucheur et al,39 2004 Off 20 min −6.50 −2.00
Khedr et al,33 2006 Off Immediately NA NA
Lomarev et al,25 2006 On and off 1 d and 1 mo −3.50 1.08
Brusa et al,36 2006 On 1 h −23.90 −20.80
del Olmo et al,31 2007 On 1 d NA NA
Hamada et al,34 2008 On 4 wk −4.78 0.01
Sedlácková et al,41 2009 Off Immediately 0.05 0.80
Filipović et al,37,38 2009, 2010 On and off 1 d −1.75 −1.40
Pal et al,27 2010 On 1 d and 1 mo −5.00 −1.50
Arias et al,23 2010 On and off Immediately and 1 wk −6.78 −3.83
González-García et al,29 2011 On 15 min −7.50 −0.80
Benninger et al,32 2012 On and off 1 d and 1 mo −2.10 −0.88
Maruo et al,26 2013 Off 1 h −5.90 −0.40
Shirota et al,30 2013 On 1 and 12 wk −3.91 −3.20
Nardone et al,40 2014 On 1, 12, and 24 h −1.17 −0.75

Abbreviations: NA, not available; rTMS, repetitive transcranial magnetic stimulation.

a

Medication state during assessment.

b

Changes in the motor section of the Unified Parkinson’s Disease Rating Scale-III score (post-rTMS score minus pre-rTMS score). More negative values (ie, greater decrements in the score) represent greater improvement in motor symptoms following rTMS sessions.

HHS Vulnerability Disclosure